UNH - UnitedHealth's OptumRx Unveils New Transparent Drug Pricing Initiative for 2024 | Benzinga
UnitedHealth Group‘s (NYSE:UNH) OptumRx unit has a new pricing model to help manage drug costs for insurers.
Starting next year, the OptumRx Clear Trend Guarantee will offer value-based pricing for drugs. It will integrate costs from various sources such as retail pharmacies, home delivery, specialty drugs, and rebates.
Value-based pricing means that payments for medicines will be linked to patient outcomes. This involves insurers, pharmaceutical companies, and pharmacy benefit management (PBMs) like OptumRx.
Related: Analysts Raises Forecasts On UnitedHealth On Controlled Growth Strategy After ...